| RS2114496205 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114496422 |
TNFAIP3
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome, familial |
| RS2114496684 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114496900 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114497046 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114499502 |
PRDM13
|
Health Risk |
Pathogenic |
Cerebellar dysfunction, impaired intellectual development |
| RS2114499761 |
TNFAIP3
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, familial |
| RS2114499988 |
PRDM13
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, IIA 17 |
| RS2114499999 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114500026 |
PRDM13
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, IIA 17 |
| RS2114500035 |
PRDM13
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, IIA 17 |
| RS2114500822 |
TNFAIP3
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, familial |
| RS2114501072 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114501078 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114501230 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS2114501370 |
TNFAIP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autoinflammatory syndrome, familial |
| RS2114501598 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114502128 |
TNFAIP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2114502447 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114502893 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114502928 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114503272 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114504458 |
TNFAIP3
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, familial |
| RS2114504766 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114505190 |
TNFAIP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2114506070 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114506723 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114507395 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, Arginase deficiency |
| RS2114519176 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, Arginase deficiency |
| RS2114532848 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114532949 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114532990 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Abnormality of the musculature |
| RS2114533123 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114537397 |
TRDN
|
Health Risk |
Likely pathogenic |
— |
| RS2114537918 |
TRDN
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2114539596 |
ARG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Arginase deficiency, Arginase deficiency |
| RS2114540946 |
SIM1
|
Health Risk |
Pathogenic |
Obesity due to SIM1 deficiency, Obesity due to SIM1 deficiency |
| RS2114544574 |
ARG1
|
Health Risk |
Likely pathogenic |
Arginase deficiency, Arginase deficiency |
| RS2114545947 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, Arginase deficiency |
| RS2114546081 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, Arginase deficiency |
| RS2114547911 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, Arginase deficiency |
| RS2114549176 |
ARG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Arginase deficiency, Arginase deficiency |
| RS2114549524 |
ARG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Arginase deficiency, Arginase deficiency |
| RS2114549604 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, Arginase deficiency |
| RS2114551021 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, Arginase deficiency |
| RS2114551140 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, Arginase deficiency |
| RS2114568240 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114568250 |
LAMA2
|
Health Risk |
Pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2114568387 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114593143 |
OSTM1
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 5, Autosomal recessive osteopetrosis 5 |
| RS2114593280 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114593373 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114593440 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114593621 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114593671 |
LAMA2
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2114606394 |
OSTM1
|
Health Risk |
Pathogenic |
— |
| RS2114606433 |
OSTM1
|
Health Risk |
Pathogenic |
— |
| RS2114611238 |
HIVEP2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2114611483 |
HIVEP2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2114611687 |
HIVEP2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2114619908 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114620061 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114620232 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114627220 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114627508 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114628933 |
RTN4IP1
|
Health Risk |
Likely pathogenic |
— |
| RS2114643507 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS2114653975 |
HIVEP2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2114654019 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114664519 |
HIVEP2
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2114670709 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114671870 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114674305 |
NUS1
|
Health Risk |
Pathogenic |
— |
| RS2114674308 |
NUS1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 55 |
| RS2114674385 |
NUS1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type IAA |
| RS2114674415 |
NUS1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 55 |
| RS2114674584 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114674819 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114677062 |
RTN4IP1
|
Health Risk |
Pathogenic |
Optic atrophy 10 with or without ataxia, intellectual disability |
| RS2114680188 |
RTN4IP1
|
Health Risk |
Likely pathogenic |
— |
| RS2114681987 |
RTN4IP1
|
Health Risk |
Pathogenic |
— |
| RS2114687510 |
NUS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, type IAA |
| RS2114687537 |
NUS1
|
Health Risk |
Likely pathogenic |
— |
| RS2114691078 |
RTN4IP1
|
Health Risk |
Pathogenic |
Optic atrophy 10 with or without ataxia, intellectual disability |
| RS2114693876 |
NUS1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 55 |
| RS2114693896 |
NUS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital disorder of glycosylation, type IAA |
| RS2114693926 |
NUS1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type IAA |
| RS2114696019 |
NUS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital disorder of glycosylation, type IAA |
| RS2114697790 |
LAMA2
|
Health Risk |
Likely pathogenic |
See cases, Merosin deficient congenital muscular dystrophy |
| RS2114699560 |
TRDN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2114700273 |
ENPP1
|
Health Risk |
Likely pathogenic |
— |
| RS2114702042 |
ENPP1
|
Health Risk |
Likely pathogenic |
Arterial calcification, generalized |
| RS2114702198 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS2114706946 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS2114710332 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS2114715466 |
ENPP1
|
Health Risk |
Likely pathogenic |
— |
| RS2114715547 |
ENPP1
|
Health Risk |
Likely pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS2114726975 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS2114727013 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS2114728448 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |